Log in or Sign up for Free to view tailored content for your specialty!
Neurology News
Medications to treat agitation in dementia have no significant effect on cognition
A systematic review and meta-analysis of trial literature found that medications investigated for treatment of agitation in dementia demonstrated no significant effect on cognition, according to a poster presentation at CTAD.
Phase 2/3 trial of Alzheimer’s therapy permitted to continue by monitoring board
Annovis Bio has been permitted by the Data and Safety Monitoring Board to continue its phase 2/3 trial of buntanetap, an oral protein inhibitor for moderate to mild Alzheimer’s disease, according to a company release.
Log in or Sign up for Free to view tailored content for your specialty!
COVID-19 mitigating factor in self-perceived cognitive decline for older adults
In a cohort of older adults, the COVID-19 pandemic was a mitigating factor in self-perceived cognitive decline, the presence of which indicated a higher risk factor for worsening cognitive function in the year following the pandemic.
Association strong between MCI, related comorbidities, but decreases with age
For early detection of Alzheimer’s disease in older adults, comorbidities remained strongly associated with mild cognitive impairment, but prediction decreased with age, according to a poster presentation at CTAD.
Navigating legal hurdles before and after signing an employment contract
As millennial and older physicians can verify, the path to becoming a physician is long and arduous, filled with years of rigorous education, exams and residency training.
Machine learning model most accurately predicts levels of cognitive impairment
An artificial intelligence-based machine learning model that diagnosed cognitive impairment in Alzheimer’s disease extracted information more accurately than standard screening or human analysis, according to a poster presentation at CTAD.
‘Reset your tech life’ with a 24-hour smartphone fast
DENVER — Addiction expert Anna Lembke, MD, invited the Lifestyle Medicine 2023 health care audience to do a 24-hour fast from their smartphones and other digital devices.
Devices implanted into brain tumors during surgery may guide treatment
An implantable microdevice designed to test treatments in patients with gliomas during standard-of-care surgery has been easily and safely incorporated into surgical practice.
Neurocognitive composite accurately detected symptom worsening in Alzheimer’s
Time-dependent worsening of cognition and function among a cohort of individuals with biomarker-proven Alzheimer’s disease or dementia was accurately detected by a composite neurocognitive measure.
Eye-tracking AI device aids in detection of dementia risk in underrepresented group
A novel, eye-tracking metrics device aided in the detection of dementia risk in a small population of Colombian individuals with differing levels of education, according to a poster presented at CTAD.
-
Headline News
NIH finds neuroscience director engaged in research misconduct
September 26, 20241 min read -
Headline News
Q&A: Phone app uses AI technology to personalize allergy forecasts
September 25, 20243 min read -
Headline News
FDA grants fast track designation to brepocitinib for noninfectious uveitis
September 25, 20241 min read
-
Headline News
NIH finds neuroscience director engaged in research misconduct
September 26, 20241 min read -
Headline News
Q&A: Phone app uses AI technology to personalize allergy forecasts
September 25, 20243 min read -
Headline News
FDA grants fast track designation to brepocitinib for noninfectious uveitis
September 25, 20241 min read